Related Experiment Video
Updated: Jul 25, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus
Arturo Valle-Mendiola1, Adriana Gutiérrez-Hoya1,2, Isabel Soto-Cruz1
1Molecular Oncology Laboratory, Cell Differentiation and Cancer Research Unit, FES Zaragoza, National University of Mexico, Batalla 5 de Mayo s/n, Colonia Ejército de Oriente, Mexico City 09230, Mexico.
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in cervical cancer progression. Inhibiting this pathway, often activated by human papillomavirus (HPV) oncoproteins, shows promise for cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- The Janus kinase (JAK)/signal transducer and activation of transcription (STAT) pathway is a critical cell surface-to-nucleus signaling module.
- Dysregulation of the JAK/STAT pathway contributes to cancer progression, metastasis, and poor prognosis, particularly in cervical cancer.
- Human papillomavirus (HPV) oncoproteins E6 and E7 are key drivers of cervical cancer, activating the JAK/STAT pathway.
Purpose of the Study:
- To review the role of JAK/STAT pathway components in cervical cancer.
- To elucidate the involvement of HPV oncoproteins in activating JAK/STAT signaling and promoting malignancy.
- To highlight the therapeutic potential of inhibiting the JAK/STAT pathway in cancer treatment.
Main Methods:
- Literature review of studies on JAK/STAT signaling, cervical cancer, and HPV oncoproteins.
- Analysis of the crosstalk between JAK/STAT and other signaling pathways in tumor growth.
- Discussion of the role of STAT proteins in cervical cancer progression and prognosis.
Main Results:
- Constitutive activation of STAT proteins is linked to poor prognosis in cervical cancer.
- HPV oncoproteins E6 and E7 activate the JAK/STAT pathway, driving proliferation, survival, and migration.
- Complex crosstalk exists between JAK/STAT and other signaling pathways, contributing to tumor growth.
Conclusions:
- The JAK/STAT pathway is a significant contributor to cervical cancer development and progression.
- Targeting the JAK/STAT pathway, in conjunction with understanding HPV oncoprotein roles, offers a promising therapeutic strategy.
- Further research into JAK/STAT inhibition could lead to novel treatments for cervical cancer.
Related Concept Videos
What is Cell Signaling?
Intracellular Signaling Cascades
Cell-surface Signaling
Overview of Cell Signaling
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway

